Compliance & EnforcementFalse Claims Act
ArchiveFalse Claims Act
3,592 articles from the Compliance & Enforcement Brief.
Articles
🔒 Members Only · Compliance & Enforcement BriefYou’ve reached the member portion of this brief.Members read the full analysis and the source documents in every Brief, six days a week.
Another Escobar Exemplar: District of New Jersey Finds Materiality Lacking
Refusal to Engage in Fraudulent Activity Also a Protected Activity; United States District Court for the Central District of California No. CV 17-8446 PSG (JPRx), U.S. ex rel. Charles Puhl v. Terumo BCT, et al.
State Audits Identified Individual Invalid Claims, but Did Not Put State on Notice of Ongoing Misconduct; United States District Court for the Central District of California No. CV 14-6891-DMG (RZx), U.S. ex rel. Judith Zissa v. Santa Barbara County Alcohol, Drug, & Mental Health Services, et al.
The Thrill of Victory and the Agony of Calculating Damages
DME Provider to Plead Guilty to $109 Million Medicare Fraud Scheme
Indivior Solutions Pleads Guilty to False Statements and Agrees to Pay $600 Million to Resolve Criminal and Civil investigations for Marketing of Opioid Addiction Treatment Drug Suboxone
Failure to Meet Academic Accreditation Guidelines Not Automatically Material to Government’s Grant Funding; United States District Court for the District of New Jersey Civ. No. 16-1817 (RMB/KMW), U.S. ex rel. Sharon Lampkin v. Pioneer Education LLC, et al.
New Evidence Supports Governments’ Late Intervention in Healthcare Fraud Case; United States District Court for the Middle District of Tennessee, Nashville Division, No. 3:17-cv-00689, U.S. and Tennessee ex rel. Gary Odom and Ross Lumpkin v. Southeast Eyes Specialists PLLC, et al.
Computer Sciences Corporation and NYC Pay $2.775 Million to Settle Medicaid Billing Fraud Case
Department of Commerce Scope Ruling Renders Defendants’ Import Statements False, but Scienter Still in Question; United States District Court for the Central District of California No. 2:17-cv-04393-RGK-KS, U.S. ex rel. Island Industries v. Vandewater International Inc., et al
Court Declines to Grant Stay When Outside Proceedings and Appeals Have Indefinite Duration; United States District Court for the Central District of California No. 2:17-cv-04393-RGK-KS, U.S. ex rel. Island Industries v. Vandewater International Inc., et al
Department of Justice Intends To Scrutinize Role of Litigation Funding in Qui Tam Lawsuits
The Government Is Here to Help—For Now: What Your Company Should Be Doing today to Protect Against Inevitable Government Scrutiny of COVID-19 Relief Funding
Relator Had Knowledge of Misconduct but Not Actual False Claims; United States District Court for the Northern District of Ohio No. 1:15cv2355, U.S. ex rel. Girishwar Sharma v. Miraca Life Sciences Inc.
Summary Judgment Inappropriate When Many Facts Remain in Dispute; United States District Court for the Eastern District of Pennsylvania No. 02-2964, U.S. ex rel. Yoash Gohil v. Sanofi U.S. Services Inc., et al.
Drug Testing Lab Pays Nearly $12 Million to Settle False Claims Act Allegations
Government Claims Based on AKS Violations False as a Matter of Law; United States District Court for the Middle District of Tennessee, Nashville Division No. 3:13-cv-0760, U.S. ex rel. Gregory M. Goodman v. Arriva Medical LLC, et al.
Relator Waived Ability to Claim Original Source Exception to Public Disclosure Bar; United States Court of Appeals for the Sixth Circuit No. 19-3646, U.S. ex rel. Kathi Holloway v. Heartland Hospice Inc., et al.
The Government Is Here to Help—For Now: What Your Company Should Be Doing today to Protect Against Inevitable Government Scrutiny of COVID-19 Relief Funding
Keep reading
